Artivion completes acquisition of Israeli medtech Endospan

What's the deal? Artivion, a US-based medical devices company focused on aortic disease, has completed its acquisition of Endospan Ltd., an Israeli medtech firm that develops endovascular devices for treating aortic arch conditions.

The deal strengthens Artivion's portfolio in minimally invasive aortic repair technologies, adding Endospan's proprietary stent graft systems to its existing product line.

Why now? The aortic device market is growing as ageing populations drive demand for less invasive treatment options. Artivion has been on an acquisition spree to consolidate its position as a comprehensive aortic care platform, and Endospan's technology fills a gap in its arch treatment capabilities.

The signal: The deal reflects a broader trend of large medtech players snapping up specialised startups to round out their product portfolios — particularly in cardiovascular and aortic care, where innovation in minimally invasive procedures commands premium valuations.

Read more: prnewswire.com